» Articles » PMID: 33715085

The Effect of Dietary Approaches to Stop Hypertension (DASH) Diet on Attention-deficit Hyperactivity Disorder (ADHD) Symptoms: a Randomized Controlled Clinical Trial

Overview
Journal Eur J Nutr
Date 2021 Mar 14
PMID 33715085
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The dietary approaches to stop hypertension (DASH) diet have several components like high amounts of fruits, vegetables, low-fat dairy products, and vitamin C and low amounts of simple sugars that might improve attention-deficit hyperactivity disorder (ADHD) symptoms. We aimed to investigate the effect of a DASH diet on children (aged 6-12 years) with ADHD, for the first time.

Methods: Participants were randomized to receive a DASH or a control diet for 12 weeks. The severity of ADHD symptoms [determined by abbreviated 10-item Conner's scale (ACS), 18-item Swanson, Nolan and Pelham (SNAP-IV) scale and strengths and difficulties questionnaire (SDQ)] were assessed every four weeks.

Results: Eighty children completed the study. After adjustment for confounders, parent (- 4.71 for the DASH group vs. - 3 for the control group) and teacher-reported (- 5.35 vs. - 1.87) ACS scores, parent-, teacher-, child-reported hyperactivity (- 1.40 vs. - 0.66, - 1.95 vs. -0.63, - 1.60 vs. - 0.43, respectively), emotional symptoms (- 1.50 vs. - 0.45, - 1.42 vs. - 0.63, and - 1.09 vs. - 0.61, respectively), and total SDQ scores (- 3.81 vs. - 1.65, - 4.11 vs. - 1.23, - 4.44 vs. - 1.26, respectively), teacher-reported of conduct problems (- 1.42 vs. - 0.63), peer relationship problems (- 0.87 vs. - 0.07), and prosocial behaviors (1.36 vs. 0.08) assessed by the SDQ were significantly improved in the DASH group compared with the control group (P < 0.05).

Conclusion: Adherence to a DASH-style diet might improve ADHD symptoms. Further RCTs which include participants from both sexes and with longer follow-up periods are needed to warrant current findings (The trial registration code: IRCT20130223012571N6; http://irct.ir/trial/12623 ). Trial registration Trial registration number: The trial was registered in the Iranian registry of clinical trials (registration code: IRCT20130223012571N6), URL: http://irct.ir/trial/12623 .

Citing Articles

The SASOP/PsychMg child and adolescent attention-deficit/hyperactivity disorder guidelines.

Belsham B, Kelly L, Schoeman R S Afr J Psychiatr. 2025; 31:2357.

PMID: 40061576 PMC: 11886469. DOI: 10.4102/sajpsychiatry.v31i0.2357.


Dietary Interventions and Supplements for Managing Attention-Deficit/Hyperactivity Disorder (ADHD): A Systematic Review of Efficacy and Recommendations.

Abhishek F, Gugnani J, Kaur H, Damera A, Mane R, Sekhri A Cureus. 2024; 16(9):e69804.

PMID: 39429382 PMC: 11491108. DOI: 10.7759/cureus.69804.


Attention-deficit/hyperactivity disorder.

Faraone S, Bellgrove M, Brikell I, Cortese S, Hartman C, Hollis C Nat Rev Dis Primers. 2024; 10(1):11.

PMID: 38388701 DOI: 10.1038/s41572-024-00495-0.


Nutrition in the Management of ADHD: A Review of Recent Research.

Lange K, Lange K, Nakamura Y, Reissmann A Curr Nutr Rep. 2023; 12(3):383-394.

PMID: 37505402 PMC: 10444659. DOI: 10.1007/s13668-023-00487-8.


Dietary Approaches to Stop Hypertension (DASH) diet and mental well-being: a systematic review.

Tan J, Wang C, Tomiyama A Nutr Rev. 2023; 82(1):60-75.

PMID: 37085157 PMC: 10711436. DOI: 10.1093/nutrit/nuad038.


References
1.
Swanson J, Eugene Arnold L, Kraemer H, Hechtman L, Molina B, Hinshaw S . Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord. 2008; 12(1):15-43. DOI: 10.1177/1087054708319525. View

2.
Kieling C, Kieling R, Rohde L, Frick P, Moffitt T, Nigg J . The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry. 2010; 167(1):14-6. PMC: 4478075. DOI: 10.1176/appi.ajp.2009.09060796. View

3.
Klein R, Mannuzza S, Ramos Olazagasti M, Roizen E, Hutchison J, Lashua E . Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry. 2012; 69(12):1295-303. PMC: 3597443. DOI: 10.1001/archgenpsychiatry.2012.271. View

4.
Polanczyk G, Silva de Lima M, Horta B, Biederman J, Rohde L . The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164(6):942-8. DOI: 10.1176/ajp.2007.164.6.942. View

5.
Biederman J . Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005; 57(11):1215-20. DOI: 10.1016/j.biopsych.2004.10.020. View